Entering text into the input field will update the search result below

Varian Medical Systems, Inc. (VAR) CEO Dow Wilson on Q2 2020 Results - Earnings Call Transcript

May 04, 2020 10:52 PM ETVarian Medical Systems, Inc. (VAR)
SA Transcripts profile picture
SA Transcripts

Varian Medical Systems, Inc. (NYSE:VAR) Q2 2020 Earnings Conference Call May 4, 2020 4:30 PM ET

Company Participants

Anshul Maheshwari - Vice President, Treasury and Investor Relations

Dow Wilson - President and Chief Executive Officer

Michael Bruff - Chief Financial Officer

Chris Toth - President, Oncology Systems

Conference Call Participants

Amit Hazan - Goldman Sachs

Matthew Taylor - UBS Securities LLC

Marie Thibault - BTIG Research

Anthony Petrone - Jefferies

Jason Bednar - Piper Sandler

Jeffrey Johnson - Robert W. Baird & Co.

Vijay Kumar - Evercore ISI

Tycho Peterson – JPMorgan


Good day, ladies and gentlemen, and welcome to Varian’s Fiscal Second Quarter 2020 Earnings Call. As a reminder, this conference call is being recorded, and a replay can be accessed on the Varian Investor website at www.varian.com/investors.

Now, I will turn it over to Anshul Maheshwari, Vice President of Investor Relations and Treasurer. Thank you. You may begin.

Anshul Maheshwari

Thank you, operator. Good afternoon, everyone, and welcome to Varian’s fiscal second quarter 2020 earnings call. Joining me today on the call are Varian’s President and Chief Executive Officer, Dow Wilson; Chief Financial Officer, Mike Bruff; and President of Oncology Systems, Chris Toth.

Today, we will be – we will cover our second quarter performance and discuss the impact of COVID-19 on our business.

On the Varian Investor Relations website, you can find our fiscal second quarter 2020 press release and earnings presentation, which are intended to provide additional perspective and details. A webcast of this call and any accompanying non-GAAP reconciliations are available on our website at www.varian.com/investorrs.

Unless otherwise stated, all financial results discussed are non-GAAP, all reference to EPS are to net earnings per diluted shares, all growth rates are year-over-year, and any references to orders are gross orders. All reference to organic growth exclude the impact of FX

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

More on VAR

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.